Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28782599 | 1.00 | GSR (0.38) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL3457786 | 0.95 | GSR (0.44) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL29104362 | 0.90 | — | — | |
| SCHEMBL3780217 | 0.90 | GSR (0.45) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL8414157 | 0.88 | GSR (0.41) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL2020673 | 0.88 | GSR (0.43) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL6342863 | 0.87 | GSR (0.42) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL27489596 | 0.84 | GSR (0.44) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL5010331 | 0.84 | GSR (0.53) | GSRCYP1A2DPP4DPP7DPP8 | |
| SCHEMBL1191631 | 0.84 | GSR (0.53) | GSRCYP1A2DPP4DPP7DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116019801-B | Amino acid composition for promoting secretion of endogenous growth hormone | 再造再生健康科技(杭州)有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116019801-A | Amino acid composition for promoting secretion of endogenous growth hormone | 再造再生健康科技(杭州)有限公司 | 2023-04-28 | — | — | CN | claimed |
| US-11504351-B2 | Methods for restoring stem cell pools and reducing epigenetic age | DISCHLER LOUIS (US) | 2022-11-22 | — | — | US | claimed |
| US-20220273690-A1 | Edible Formulations Based on Active Ingredients and Arginine | GRAAL S R L (IT) | 2022-09-01 | — | — | US | claimed |
| US-20220257558-A1 | METHODS FOR RESTORING STEM CELL POOLS AND REDUCING EPIGENETIC AGE | DISCHLER LOUIS (US) | 2022-08-18 | — | — | US | claimed |
| EP-4021508-A1 | FORMULATIONS COMPRISING ARGININE AND/OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AN ACID ACTIVE INGREDIENT WITH A PKA OF 1 -5 | Graal S.r.l. (IT) | 2022-07-06 | — | — | EP | claimed |
| US-11344528-B2 | Compositions for promoting the endogenous self-renewal of stem cells | DISCHLER LOUIS (US) | 2022-05-31 | — | — | US | claimed |
| US-11324764-B2 | Methods for reducing mitochondrial dysfunction | DISCHLER LOUIS (US) | 2022-05-10 | — | — | US | claimed |
| EP-3595637-B1 | COMBINATION OF ACTIVE INGREDIENTS, COMPOSITIONS COMPRISING IT AND THEIR USE IN THE TREATMENT OF SARCOPENIA | APHARM SRL (IT) | 2021-08-18 | — | — | EP | claimed |
| US-11090320-B2 | Compositions for reducing mitochondrial dysfunction | DISCHLER LOUIS (US) | 2021-08-17 | — | — | US | claimed |
| US-8168241-B2 | For enhancing physical performance of human, foods | RELIV INTERNATIONAL, INC. (US) | 2012-05-01 | — | — | US | claimed |
| WO-2012024291-A1 | METHODS FOR PREPARING A FERMENTED GINSENG CONCENTRATE OR POWDER | ILHWA CO. LTD (US) | 2012-02-23 | — | — | WO | claimed |
| US-20120045428-A1 | METHODS FOR PREPARING A FERMENTED GINSENG CONCENTRATE OR POWDER | IL HWA CO., LTD. (US) | 2012-02-23 | — | — | US | claimed |
| EP-2020999-A1 | COMPOSITIONS COMPRISING ALPHA-KETOGLUTARATE AND THEIR USE FOR MODULATING MUSCLE PERFORMANCE | SGP & SONS AB (SE) | 2009-02-11 | — | — | EP | claimed |
| WO-2007122190-A1 | COMPOSITIONS COMPRISING ALPHA-KETOGLUTARATE AND THEIR USE FOR MODULATING MUSCLE PERFORMANCE | SGP & SONS AB (SE) | 2007-11-01 | — | — | WO | claimed |
| EP-1737482-A2 | COMPOSITIONS AND METHODS FOR TREATING DISEASES | Lumen Therapeutics, LLC (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2005084301-A2 | COMPOSITIONS AND METHODS FOR TREATING DISEASES | LUMEN THERAPEUTICS, LLC (US) | 2005-09-15 | — | — | WO | claimed |
| US-20050090545-A1 | Nitric oxide topical technology | LEITMAN LORN (US) | 2005-04-28 | — | — | US | claimed |
| US-20010041187-A1 | PERFORMANCE-ENHANCING DIETARY SUPPLEMENT | RELIV' INTERNATIONAL, INC. | 2001-11-15 | — | — | US | claimed |
| US-5817329-A | CONTAINING ACETYL-L-CARNITINE | HSBC BANK CANADA (CA) | 1998-10-06 | — | — | US | claimed |